EOFlow

EOFlow Co., Ltd., established in 2011 by Jesse J. Kim, is a company dedicated to developing wearable drug delivery systems. Kim's professional background includes time at the multidisciplinary design and consulting firm IDEO and later founding Insulet Corporation, which developed the first commercially successful tubeless insulin pump, OmniPod. This experience in both design and medical device development directly informs EOFlow's strategic direction. The company's headquarters are located in Seongnam, South Korea.

The company's flagship product is the 'EOPatch', a disposable and wearable insulin pump designed for individuals with diabetes. Functioning as a continuous subcutaneous insulin infusion (CSII) device, the EOPatch is tubeless and can be worn for up to 3.5 days. This design aims to offer greater freedom and convenience compared to traditional insulin pumps with tubing. The device is managed through the 'Narsha' smartphone application, which allows users to monitor their insulin delivery and glucose levels. The application is available on both Android and iOS platforms. Another key component of their system is the 'EOPump', a compact, disposable insulin reservoir with an integrated infusion set, which underpins the functionality of the EOPatch.

EOFlow operates in the competitive diabetes care market, specifically targeting the segment of insulin-dependent patients who require precise and continuous insulin management. Its business model centers on the sale of these disposable medical devices. The company has achieved several key milestones, including obtaining Korea's Ministry of Food and Drug Safety (MFDS) approval for the EOPatch in 2021. Following this, EOFlow secured a CE mark in Europe, also in 2021, paving the way for commercialization in that region. The company has also pursued entry into the U.S. market, submitting a 510(k) premarket notification to the FDA. In 2023, global medical technology firm Medtronic announced its intention to acquire EOFlow, signaling a significant valuation of the company's technology and market position.

Keywords: wearable drug delivery, insulin pump, diabetes care, medical device, continuous subcutaneous insulin infusion, EOPatch, digital healthcare, medtech, disposable pump, connected health